KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
Oct 17, 2019 $2.47 $2.49 $2.24 $2.33 11 145
Oct 16, 2019 $2.34 $2.42 $2.27 $2.27 10 185
Oct 15, 2019 $2.34 $2.36 $2.26 $2.32 5 420
Oct 14, 2019 $2.25 $2.34 $2.18 $2.31 11 951
Oct 11, 2019 $2.31 $2.31 $2.12 $2.12 7 539
Oct 10, 2019 $2.07 $2.49 $2.07 $2.25 63 134
Oct 09, 2019 $2.40 $2.42 $2.02 $2.02 81 146
Oct 08, 2019 $2.42 $2.42 $2.37 $2.37 10 746
Oct 07, 2019 $2.52 $2.63 $2.37 $2.41 30 390
Oct 04, 2019 $2.44 $2.66 $2.42 $2.66 4 404
Oct 03, 2019 $2.59 $2.76 $2.41 $2.45 1 985
Oct 02, 2019 $2.62 $2.62 $2.48 $2.48 5 625
Oct 01, 2019 $2.57 $2.69 $2.43 $2.66 14 492
Sep 30, 2019 $2.58 $2.73 $2.41 $2.59 10 439
Sep 27, 2019 $2.69 $2.69 $2.60 $2.60 3 388
Sep 26, 2019 $2.66 $2.69 $2.60 $2.69 1 470
Sep 25, 2019 $2.63 $2.70 $2.63 $2.66 7 109
Sep 24, 2019 $2.70 $2.75 $2.64 $2.70 3 712
Sep 23, 2019 $2.79 $2.81 $2.75 $2.78 6 870
Sep 20, 2019 $2.57 $2.77 $2.50 $2.77 23 870
Sep 19, 2019 $2.68 $2.69 $2.45 $2.45 5 524
Sep 18, 2019 $2.72 $2.73 $2.60 $2.61 8 110
Sep 17, 2019 $2.36 $2.75 $2.26 $2.66 56 135
Sep 16, 2019 $2.43 $2.43 $2.30 $2.34 4 895
Sep 13, 2019 $2.45 $2.59 $2.42 $2.46 15 832
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT